HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia.

AuthorsPaul S Covington, J Michael Davenport, David A Andrae, Martin E Stryjewski, Lisa L Turner, Gail McIntyre, June Almenoff
JournalThe Journal of antimicrobial chemotherapy (J Antimicrob Chemother) Vol. 68 Issue 11 Pg. 2691-3 (Nov 2013) ISSN: 1460-2091 [Electronic] England
PMID23749951 (Publication Type: Clinical Trial, Phase II, Letter, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • 7-(3-(2-amino-1-fluoroethylidene)-1-piperidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
  • Anti-Bacterial Agents
  • Fluoroquinolones
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents (therapeutic use)
  • Bacteria (classification, isolation & purification)
  • Community-Acquired Infections (drug therapy)
  • Female
  • Fluoroquinolones (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Pneumonia, Bacterial (drug therapy)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: